Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
Company Contact | |
Address: | 7 Ha'eshel St., PO Box 3163 CAESAREA 3079504 |
Tel: | N/A |
Website: | https://icecure-medical.com |
IR: | See website |
Key People | ||
Ron Abraham Mayron Chairman of the Board | Eyal Shamir Chief Executive Officer, Director | Ronen Tsimerman Vice President - Finance, Vice President - Operations |
Elisabeth Sadka Vice President-Clinics, Regulations and Quality Assurance | Naum Muchnik Vice President - Research & Development | Tlalit Bussi Tel-Tzure Vice President - Business Development & Marketing |
Business Overview |
Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized. |
Financial Overview |
For the fiscal year ended 31 December 2023, Icecure Medical Ltd revenues increased 5% to $3.2M. Net loss decreased 14% to $14.7M. Revenues reflect China segment increase from $104K to $440K, Other segment increase of 28% to $1.5M. Lower net loss reflects General and administrative expen decrease of 37% to $2.3M (expense), Financing Income/Expenses, Net increase from $239K (expense) to $924K (income). |